01 7Bilanoa
Main Therapeutic Indication : Immunology
Currency : USD
2020 Revenue in Millions : 95
2019 Revenue in Millions : 116
Growth (%) : -18
Main Therapeutic Indication : Immunology
Currency : USD
2021 Revenue in Millions : 96
2020 Revenue in Millions : 91
Growth (%) : 14
Main Therapeutic Indication : Immunology
Currency : USD
2022 Revenue in Millions : 100
2021 Revenue in Millions : 96
Growth (%) : 4
Main Therapeutic Indication : Immunology
Currency : USD
2023 Revenue in Millions : 92
2022 Revenue in Millions : 100
Growth (%) : 5
Main Therapeutic Indication : Anti-allergic
Currency : USD
2017 Revenue in Millions : 19
2016 Revenue in Millions : 21
Growth (%) : -9
Main Therapeutic Indication : Anti-allergic
Currency : USD
2018 Revenue in Millions : 59
2017 Revenue in Millions : 18
Growth (%) : 230%
Main Therapeutic Indication : Immunology
Currency : USD
2019 Revenue in Millions : 113
2018 Revenue in Millions : 61
Growth (%) : 85
LOOKING FOR A SUPPLIER?
